JAID/JSC Guidelines for Infection Treatment 2015−Intestinal infections
Abstract
Intestinal infection is a disease of global importance because of the large number of patients. The causative microorganisms vary widely, including bacteria, viruses, parasites, and fungi, but bacteria and viruses are primary pathogens in immunologically normal individuals. Patients with parasitosis also occasionally consult medical institutions. There are drugs effective for some of these pathogenic organisms, but their use varies among individual physicians or facilities.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.